Pharvaris BV (PHVS) financial statements
Net income was -176M EUR.
Free cash flow was -137M EUR.
The diluted share count rose 1120% over the period (dilution).
Income statement
Fiscal years, in EUR, from Pharvaris BV's 10-K filings with the SEC.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Research and development | 4M EUR | 6M EUR | 20M EUR | 36M EUR | 57M EUR | 66M EUR | 99M EUR | 124M EUR |
| Selling, general and admin | 668,121 EUR | 2M EUR | 5M EUR | 18M EUR | 29M EUR | 31M EUR | 47M EUR | 45M EUR |
| Operating income | -4M EUR | -8M EUR | -26M EUR | -43M EUR | -76M EUR | -100M EUR | -132M EUR | -174M EUR |
| Interest expense | 380 EUR | 16,881 EUR | 92,470 EUR | 267,510 EUR | 16,105 EUR | — | — | — |
| Pre-tax income | -4M EUR | -8M EUR | -26M EUR | -43M EUR | -76M EUR | -100M EUR | -132M EUR | -174M EUR |
| Income tax | 0 EUR | 0 EUR | -83,251 EUR | 70,117 EUR | 679,087 EUR | 1M EUR | 2M EUR | 2M EUR |
| Net income | -4M EUR | -8M EUR | -26M EUR | -43M EUR | -76M EUR | -101M EUR | -134M EUR | -176M EUR |
| EPS (diluted) | — | — | — | -1.40 EUR | -2.27 EUR | -2.63 EUR | -2.48 EUR | -2.97 EUR |
| Diluted shares | 5M | 5M | 5M | 30M | 34M | 38M | 54M | 59M |
Balance sheet
Fiscal years, in EUR, from Pharvaris BV's 10-K filings with the SEC.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | 5M EUR | 20M EUR | 99M EUR | 209M EUR | 162M EUR | 391M EUR | 281M EUR | 292M EUR |
| Receivables | — | 210,843 EUR | 569,578 EUR | 700,079 EUR | 382,468 EUR | 1M EUR | 3M EUR | 5M EUR |
| Property, plant and equipment | 0 EUR | 12,927 EUR | 48,503 EUR | 108,098 EUR | 193,474 EUR | 223,678 EUR | 667,000 EUR | 642,470 EUR |
| Total assets | — | 21M EUR | 101M EUR | 212M EUR | 168M EUR | 399M EUR | 291M EUR | 301M EUR |
| Total liabilities | — | 2M EUR | 5M EUR | 7M EUR | 18M EUR | 15M EUR | 24M EUR | 30M EUR |
| Shareholders' equity | 5M EUR | 19M EUR | 96M EUR | 205M EUR | 149M EUR | 384M EUR | 268M EUR | 271M EUR |
| Net debt | -5M EUR | -20M EUR | -99M EUR | -209M EUR | -162M EUR | -391M EUR | -281M EUR | -292M EUR |
Cash flow
Fiscal years, in EUR, from Pharvaris BV's 10-K filings with the SEC.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -4M EUR | -7M EUR | -21M EUR | -45M EUR | -67M EUR | -93M EUR | -120M EUR | -137M EUR |
| Capital spending | 0 EUR | 13,476 EUR | 42,977 EUR | 130,032 EUR | 124,296 EUR | 89,984 EUR | 538,086 EUR | 164,619 EUR |
| Free cash flow | -4M EUR | -7M EUR | -22M EUR | -45M EUR | -67M EUR | -93M EUR | -121M EUR | -137M EUR |
| Stock-based compensation | 100,745 EUR | 116,147 EUR | 2M EUR | 8M EUR | 11M EUR | 11M EUR | 16M EUR | 19M EUR |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PHVS.
Open PHVS in InvestinglyQuestions
How much free cash flow does Pharvaris BV generate?
-137M EUR in fiscal 2025 (operating cash flow minus capital spending).
From Pharvaris BV's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.